Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings
- PMID: 20806434
- PMCID: PMC2932921
- DOI: 10.3748/wjg.v16.i33.4169
Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings
Abstract
Aim: To characterize the histopathologic specifications of non-alcoholic steatohepatitis (NASH) according to age and gender.
Methods: An analytical cross-sectional study was conducted in two private gastroenterology clinics on biopsy proven patients suffering from NASH. Biopsy histopathologic findings as well as demographic and laboratory data of the patients at the time of biopsy were gathered retrospectively from clinical records. The grading and staging of histopathologic findings were performed according to the Brunt method after reevaluation of the slides by a pathologist. Patients were divided into two groups according to age (below and above 55 years). Mean quantitative grade of all pathologic findings were also calculated according to Brunt scoring values.
Results: A total number of 77 NASH patients, consisting of 58 males (75.3%) and 19 (24.7%) females with a mean age of 41.99 +/- 11.80 years (range, 18-70 years), were enrolled. The mean age (48.72 +/- 13.99 years vs 39.74 +/- 10.16 years, P = 0.004) and aspartate aminotransferase level (75.11 +/- 29.68 U/L vs 52.78 +/- 25.00 U/L, P = 0.002) was significantly higher in female patients. Mean quantitative grade of hepatosteatosis was significantly higher in females (2.00 +/- 0.82 vs 1.59 +/- 0.68, P = 0.031) compared to males. Fifty four percent (34/65) of young patients had mild hepatosteatosis (Grade I) while only one patient (11.2%) in the older group had grade I hepatosteatosis. Patients aged > or = 55 had significantly more severe hepatosteatosis (Grade III) (44.4% vs 9.5%, P = 0.007) and the mean quantitative grade of hepatosteatosis was significantly higher among them (2.33 +/- 0.71 vs 1.56 +/- 0.67, P = 0.002). Multivariate analysis after omitting the confounding role of age revealed a higher grade of hepatosteatosis in female patients (P = 0.010).
Conclusion: These findings point toward the possible influence of age in the severity of steatohepatitis, portal and lobar inflammation in patients suffering from NASH while gender independently might contribute to the level of steatohepatitis.
Figures
Similar articles
-
Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings.Hepat Mon. 2011 Jun;11(6):452-8. Hepat Mon. 2011. PMID: 22087177 Free PMC article.
-
Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis.Dig Dis Sci. 2008 Jul;53(7):1967-76. doi: 10.1007/s10620-007-0074-0. Epub 2007 Nov 21. Dig Dis Sci. 2008. PMID: 18030620
-
[Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].Rev Invest Clin. 2005 Jul-Aug;57(4):505-12. Rev Invest Clin. 2005. PMID: 16315634 Spanish.
-
Histopathology, grading and staging of nonalcoholic fatty liver disease.Minerva Gastroenterol Dietol. 2018 Mar;64(1):28-38. doi: 10.23736/S1121-421X.17.02445-X. Epub 2017 Sep 25. Minerva Gastroenterol Dietol. 2018. PMID: 28948754 Review.
-
[Role of liver biopsy in the diagnosis of NASH].Nihon Rinsho. 2006 Jun;64(6):1119-25. Nihon Rinsho. 2006. PMID: 16768119 Review. Japanese.
Cited by
-
Gender specific medicine in liver diseases: a point of view.World J Gastroenterol. 2014 Mar 7;20(9):2127-35. doi: 10.3748/wjg.v20.i9.2127. World J Gastroenterol. 2014. PMID: 24605011 Free PMC article. Review.
-
Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.Exp Biol Med (Maywood). 2015 Oct;240(10):1279-86. doi: 10.1177/1535370215570189. Epub 2015 Mar 18. Exp Biol Med (Maywood). 2015. PMID: 25790822 Free PMC article.
-
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.CPT Pharmacometrics Syst Pharmacol. 2023 Dec;12(12):2038-2049. doi: 10.1002/psp4.13052. Epub 2023 Oct 3. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37750001 Free PMC article.
-
Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis.World J Hepatol. 2011 Aug 27;3(8):219-27. doi: 10.4254/wjh.v3.i8.219. World J Hepatol. 2011. PMID: 21954411 Free PMC article.
-
Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.Asian Pac J Trop Biomed. 2012 Sep;2(9):702-6. doi: 10.1016/S2221-1691(12)60213-5. Asian Pac J Trop Biomed. 2012. PMID: 23569998 Free PMC article.
References
-
- Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol. 2003;98:2042–2047. - PubMed
-
- Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994;107:1103–1109. - PubMed
-
- Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology. 1988;95:1056–1062. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical